149 related articles for article (PubMed ID: 7902324)
21. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Decker RA
Surgery; 1993 Dec; 114(6):1059-63. PubMed ID: 7903002
[TBL] [Abstract][Full Text] [Related]
22. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
[TBL] [Abstract][Full Text] [Related]
23. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
[TBL] [Abstract][Full Text] [Related]
24. Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.
Norum RA; Lafreniere RG; O'Neal LW; Nikolai TF; Delaney JP; Sisson JC; Sobol H; Lenoir GM; Ponder BA; Willard HF
Genomics; 1990 Oct; 8(2):313-7. PubMed ID: 1979053
[TBL] [Abstract][Full Text] [Related]
25. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma.
Jhiang SM; Fithian L; Weghorst CM; Clark OH; Falko JM; O'Dorisio TM; Mazzaferri EL
Thyroid; 1996 Apr; 6(2):115-21. PubMed ID: 8733882
[TBL] [Abstract][Full Text] [Related]
26. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
[TBL] [Abstract][Full Text] [Related]
27. [Familial occurrence of thyroid tumors].
Kameyama K; Takami H; Hosoda Y
Nihon Rinsho; 1995 Nov; 53(11):2697-701. PubMed ID: 8538029
[TBL] [Abstract][Full Text] [Related]
28. Dermal Hyperneury and Multiple Sclerotic Fibromas in Multiple Endocrine Neoplasia Type 2A Syndrome.
Alegría-Landa V; Jo-Velasco M; Robledo M; Requena L
JAMA Dermatol; 2017 Dec; 153(12):1298-1301. PubMed ID: 29049491
[TBL] [Abstract][Full Text] [Related]
29. Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.
Xue F; Yu H; Maurer LH; Memoli VA; Nutile-McMenemy N; Schuster MK; Bowden DW; Mao J; Noll WW
Hum Mol Genet; 1994 Apr; 3(4):635-8. PubMed ID: 7915165
[TBL] [Abstract][Full Text] [Related]
30. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
Kameyama K; Okinaga H; Takami H
Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
[TBL] [Abstract][Full Text] [Related]
31. A new polymorphic marker (D10S97) tightly linked to the multiple endocrine neoplasia type 2A (MEN2A) locus.
Lichter JB; Wu J; Brooks-Wilson AR; Difillipantonio M; Brewster S; Ward DC; Goodfellow PJ; Kidd KK
Hum Genet; 1993 Jan; 90(5):516-20. PubMed ID: 8094065
[TBL] [Abstract][Full Text] [Related]
32. Genetic analysis of 24 French families with multiple endocrine neoplasia type 2A.
Narod SA; Lavoué MF; Morgan K; Calmettes C; Sobol H; Goodfellow PJ; Lenoir GM
Am J Hum Genet; 1992 Sep; 51(3):469-77. PubMed ID: 1353939
[TBL] [Abstract][Full Text] [Related]
33. A novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma.
Alemi M; Lucas SD; Sällström JF; Akerström G; Wilander E
Anticancer Res; 1996; 16(5A):2619-22. PubMed ID: 8917360
[TBL] [Abstract][Full Text] [Related]
34. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
35. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.
Mulligan LM; Eng C; Attié T; Lyonnet S; Marsh DJ; Hyland VJ; Robinson BG; Frilling A; Verellen-Dumoulin C; Safar A
Hum Mol Genet; 1994 Dec; 3(12):2163-7. PubMed ID: 7881414
[TBL] [Abstract][Full Text] [Related]
36. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
37. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
[TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of familial medullary thyroid carcinoma.
Kameyama K; Okinaga H; Takami H
Biomed Pharmacother; 2004; 58(6-7):348-50. PubMed ID: 15271414
[TBL] [Abstract][Full Text] [Related]
39. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
40. [The molecular genetics of multiple endocrine neoplasia type 2A and 2B].
Yoshimoto K
Nihon Rinsho; 1994 Apr; 52(4):1081-6. PubMed ID: 7910861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
